This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With influenza season well underway, vaccination campaigns are in full force in the northern hemisphere. This will reshape the global influenza vaccine market for the upcoming seasons, says GlobalData. Kurdach continues, “When the actual composition of vaccines will revert to trivalent formulations remains another question.
Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but the company says the project is back on track following regulatory approval to start trials in Russia. The post Losing ground in COVID-19 vaccine race, CanSino turns to Russia appeared first on.
alleging that Pfizer’s respiratory syncytial virus (“RSV”) vaccine ABRYSVO infringes four U.S. patents covering GSK’s rival RSV vaccine, AVREXY. 8,563,002, 11,261,239, 11,629,181, and 11,655,284, as claiming inventions relating to compositions used in RSV vaccines, and methods for preparing those compositions. Patent Nos.
Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.
This period included the implementation of novel designation types: qualified infectious disease product designation (in 2012), breakthrough therapy (2013), rare pediatric drug designation (2014), and regenerative medicine advanced therapy designation (2017). Over this period, annual designations awarded by the FDA increased almost four-fold.
RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.
The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively.
billion, three times the original estimate when the project was announced in 2013. The healthy sales increase was bolstered by the timing of orders for AZ’s COVID-19 vaccine Vaxzevria , which made $1.1 billion in the quarter but is expected to make less of a contribution in the remainder of the year.
Under a public-private partnership including governments, international organisations, and private non-profit organisations, Eisai has participated in 23 joint research projects to develop new medicines and vaccines for mycetoma, malaria and filariasis, with the support of the GHIT Fund.
Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals. Union of India (4) (2013 (6) SCC 1), the Division Bench of Delhi High Court in the case of F. Hoffmann-LA Roche and Ors. Vs. Cipla (5). ILR(2009)Supp. (2)Delhi
Covid-19 promoted India to the centre stage of global vaccines export as consumerisation of health providing an impetus for vaccines and prompt approvals. Union of India4 (2013 (6) SCC 1), the Division Bench of Delhi High Court in the case of F. Hoffmann-LA Roche and Ors. Vs. Cipla5. ILR(2009)Supp.(2)Delhi
For example, rising ambient temperatures and ingress of mould from items entering cleanrooms, has resulted in some vaccine and pharmaceutical companies in Europe experiencing increased contamination. Ahmed et al. According to the authors, these were linked to 55 fatal cases of fungal meningitis.
According to research from Alacrita, a pharma and biotech consulting firm, between 2013 and 2018, nearly 50 per cent of all New Drug Applications (NDAs) approved by the FDA were based on the 505(b)(2) pathway. As the world’s largest manufacturer of generic medicines, India has vast potential to utilise repurposed drugs.
Single-use bioprocessing technologies enabling more rapid vaccines production [Internet]. He was named Head of Process Development in 2013, then promoted to Chief Scientific Officer (CSO) in 2020. Available from: [link] Nielsen J, Tillegreen CB, Petranovic D. Innovation trends in Industrial Biotechnology. Trends in Biotechnology.
These alternative positions allow them to practice pharmacy without having to adapt to pandemic-related changes – administering COVID-19 testing and vaccinations, accepting reduced staffing and lower pay, or utilizing new technologies – at the later stages of their careers.
Barr meanwhile has served at Merck for more than two decades, holding positions of increasing responsibility in infectious diseases, oncology and vaccines. Baynes will serve as a consultant to Eikon starting on 1 April 1, before transitioning to his full-time role.
Prof Salisbury was director of immunisation at the Department of Health until the end of 2013. He was responsible for the national immunisation programme and led the introduction of many new vaccines. He was awarded a CBE for patient safety in 2017.
The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” The previous record for vaccine development and approval was four years for the measles vaccine. Perhaps we will see a universal flu vaccine in the near future.
In a recent blog posting, I looked back at the profile of FDA press releases over the period 2013-2021 (See What They Said 2021 – An Overview of FDA Press Statements ). But mostly, we are just tired – there is a strong sense of COVID fatigue, not just among people, but it seems even institutions. Even perhaps FDA.
In Muratov’s opinion, this was reflective of a wider pattern seen in almost any other field of research, which could now change with the development of Covid-19 vaccines and antivirals. Four countries managed to get rid of river blindness after adopting elimination strategies, with the first being Colombia in 2013.
Total Revenue: $35.48B Founded Year: 2000 Total Employees: ~69,400 Headquarters: London, United Kingdom Market Cap: $77.61B Stock Exchange: LON GSK is a multinational healthcare company indulged in discovering and developing therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines.
Monica Mann: TECFIDERA® (dimethyl fumarate) was initially approved in the US in 2013 for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. of TECFIDERA (dimethyl fumarate).
BioNTech has said it plans to set up a regional base and new manufacturing site in Singapore so that the biotech can keep pace with demand for its mRNA-based coronavirus vaccine and pipeline products in other disease areas. BioNTech is run by husband-and-wife team Ugur Sahin and Ozlem Tureci and in 2013 hired the expertise of Kariko.
Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. The US accounts for almost half of all biotechnology patents filed worldwide from 1999 to 2013. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge.
The EMA has extended the approved indications of Bavarian Nordic’s smallpox vaccine Imvanex for monkeypox, which has now infected tens of thousands of people across dozens of countries worldwide. In June said it had received orders for 1.5 In June said it had received orders for 1.5
AstraZeneca has sold its stake in Moderna for more than $1 billion as the US biotech’s shares soared in value following its coronavirus vaccine breakthrough. Moderna was among the first companies to get a COVID-19 vaccine approved and has been selling it at a profit, even though the project was kick-started with around $1.5
Prevention Varicella virus vaccine is recommended to prevent chickenpox in adults and children ≥ 12 months old, unless immunocompromised. Give antiviral medication (e.g. acyclovir) for immunocompromised patients, patients with chronic skin or lung disease, severe cases of varicella, neonatal varicella, adults, and pregnant women.
Efforts to encourage US citizens to take their COVID-19 vaccines received a boost from country music legend Dolly Parton, who updated her hit song “Jolene” to pledge her support in a social media video showing her getting inoculated. Vaccine, vaccine, vaccine, vaccine, because once you’re dead, then it’s a bit too late.”.
As we intended, this approach has been incredibly successful in controlling costs: the Congressional Budget Office projected drug spending between 2004-2013 to be $770 billion; actual expenses were 45% lower- at $421 billion. 3] “ Democrat plan on drug costs will stifle innovation”, San Antonio Express-News, May 12, 2021 [1] [link]
Having become familiar with online healthcare and volunteering for vaccine trials during the pandemic, patients are increasingly learning about clinical trials and accessing local participating centres through websites such as Breast Cancer Study Locator.
Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart failure.
Self-Reported Diabetes Prevalence in Asian American Subgroups: Behavioral Risk Factor Surveillance System, 2013–2019. COVID-19 Cases and Deaths, Vaccinations, and Treatments by Race/Ethnicity as of Fall 2022. Shah NS, Luncheon C, Kandula NR, Cho P, Loustalot F, Fang J. J Gen Intern Med. 2022;37(8):1902-1909. Accessed May 18, 2023.
Zydus has announced the launch of VaxiFlu-4, its Quadrivalent Inactivated Influenza vaccine, for the 2025 southern hemisphere flu season. The vaccine has received clearance from the Central Drug Laboratory (CDL). In India, there is a pressing need for access to affordable, high-quality vaccines that can address healthcare challenges.
The Nobel Assembly has awarded Hungarian biochemist Katalin Karikó and US immunologist Drew Weissman the Nobel Prize in Physiology or Medicine 2023 for their breakthrough findings in RNA vaccine development. The discovery was critical for developing effective mRNA vaccines during the COVID-19 pandemic.
Newly developed vaccines will be supplied by the World Health Organization in a bid to contain the pandemic, officials said. Between 2013 and 2016 more than 11,000 people died in the West Africa Ebola epidemic that begun in Guinea. The post Guinea declares Ebola epidemic following first deaths since 2016 appeared first on.
EMA/CHMP/ICH/353369/2013. EMA/CHMP/ICH/83812/2013. Internet] Vaccines Europe. ICH Q3D(R2) Elemental Impurities – Scientific Guideline. 2 May 2022. ICH Q3E Guideline for Extractables and Leachables (E&L). Final Concept Paper. 30 June 2020. 18 July 2023. J Pharm Sci. 2024; 113: 837-855. Final concept Paper. 25 June 2024.
In a landmark 2013 decision , a unanimous Supreme Court held that a naturally occurring DNA segment, even when isolated, is a product of nature and therefore does not meet the subject matter eligibility requirement for patentability.
As the WHO noted in 2013: “Knowledge societies in the 21st century confront a health decision-making paradox. Those steps were followed in October with a new global policy that banned any adverts that would discourage people from getting vaccinated, whether for COVID, the flu or anything else. “We About the author.
She is vaccinated for COVID-19. 2013:673-675. She denied any known fever and had no known vaginal or oral lesions. She has a 5-year-old daughter at home with no known symptoms. She is sexually active with one male partner who has no rash or illness. 2018 Nov 2;10(11):609. doi: 10.3390/v10110609. McGraw Hill.
Since that book was published in 2013, I have continued to study Hashimoto’s through working with clients, connecting with readers, analyzing research, sharing knowledge and best practices with colleagues, participating in functional medicine training, and reading everything I can find on triggers and solutions for autoimmune conditions.
She reported receiving vaccines before leaving but was unsure which vaccines she received. 2013: bcr2013201598. While in Ghana, she volunteered at a refugee hospital, ate street food, and was exposed to local animals. Prior to her stay in Ghana, she spent a week in Bali. References Schaefer TJ, Panda PK, Wolford RW. StatPearls.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content